Automated liquid biopsy test predicts early disease progression, survival among patie
 

A novel, automated liquid biopsy test in development by researchers at the Johns Hopkins Kimmel Cancer Center can be used to predict early disease progression and potential survival among patients with metastatic breast cancer in as little as one month after starting treatment, according to a recent study.

More...